Here's why traders who are long Google need to pay attention.
The key question now is whether the biopharmaceutical stock can break out to the upside.
Let's take a look at the charts of this name and their implications.
Investor sentiment has become a bit less threatening.
The charts of the upscale home furnishings retailer are showing weakness.
Perhaps, but if the price doesn't hold it would be best to quickly ditch the supplier of aggregates, cement and asphalt.
Can we finally get a nice whoosh and some panic into that much anticipated oversold condition? I'd like to see it.
Here's what traders should avoid.
Should investors still sink their teeth into this one?
HUN was downgraded by TheStreet's Quant Ratings service on Tuesday.